Hyperion DeFi (HYPD) Stock Price, Quote, News & History | Benzinga

Hyperion DeFi Inc (HYPD) Stock Price, Quote, News & History

HYPDNASDAQ

Trade with Public

Trade with Public

$2.72

-0.11-3.89%

At close: Aug 14, 5:00 PM EST

$2.70

-0.02-0.74%

After Hours: 6:43 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

Conference Call: The most recent conference call started at 5:00 PM, 3 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$2.85

Close

$2.72

Volume / Avg.

157.61K / 488.13K

Day Range

$2.71 - $2.86

52 Wk Range

2.34 - 15.00

Market Cap

$40.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

10.63%

Days to Cover

6.43

Recent Hyperion DeFi Inc News

Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts ORCL PT, Needham raises APLD PT, Morgan Stanley raises AAPL PT, BTIG raises NRIX PT, GLJ Research raises CLF PT.

Avi Kapoor

Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analyst ratings page.

Avi Kapoor

Arthur Hayes' Crypto Portfolio Beyond Bitcoin, Ethereum: One Bet Has Crashes 55% YTD While Another Climbs 13%

Arthur Hayes, Chief Investment Officer at Maelstrom Fund, gave details of his investment portfolio on Sunday, including two cryptocurrencies showing starkly different year-to-date performances.

Aniket Verma

Hyperliquid Roars Past XRP, BNB With 65% Rally: Why Treasury Companies Buy The HYPE

Hyperliquid (CRYPTO: HYPE) is up 65% this week, taking the limelight from bigger and presumably more established tokens, such as XRP

Parshwa Turakhiya

This Hyperion DeFi Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.52M

Investing Cash Flow (TTM)

-73.43M

Financing Cash Flow (TTM)

91.40M

Free Cash Flow (TTM)

-87.95M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

3.45M

Analyst Trends and Forecast

1

Mar

1

Jun

1

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$42.92M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

20.61

PB Ratio (TTM)

0.73

Earnings Yield % (TTM)

-267.73%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.86

Company Debt

Total Debt

$8.47M

LT Debt

$6.97M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.37M

Total Cash

$7.38M

Debt to Equity

0.16

Issuance of Debt (TTM)

-$1.37M

Repayment of Debt (TTM)

-$1.37M

Key Statistics

Open

$2.85

Close

$2.72

Volume / Avg.

157.61K / 488.13K

Day Range

$2.71 - $2.86

52 Wk Range

2.34 - 15.00

Market Cap

$40.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

10.63%

Days to Cover

6.43

About

Sector

Health Care

Industry

Pharmaceuticals

Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Hyperion DeFi (HYPD) stock?

A

You can purchase shares of Hyperion DeFi (NASDAQ:HYPD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Hyperion DeFi (HYPD) competitors?

A

Other companies in Hyperion DeFi’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Hyperion DeFi (HYPD) stock?

A

Hyperion DeFi has a consensus price target of $6.13.

Q

What is the current price for Hyperion DeFi (HYPD)?

A

The stock price for Hyperion DeFi (NASDAQ: HYPD) is $2.7 last updated August 14, 2026 at 6:43 PM EDT.

Q

Does Hyperion DeFi (HYPD) pay a dividend?

A

There are no upcoming dividends for Hyperion DeFi.

Q

When is Hyperion DeFi (NASDAQ:HYPD) reporting earnings?

A

Hyperion DeFi does not have any upcoming earnings scheduled.

Q

Is Hyperion DeFi (HYPD) going to split?

A

There is no upcoming split for Hyperion DeFi.

Q

What sector and industry does Hyperion DeFi (HYPD) operate in?

A

Hyperion DeFi is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.